HIMS

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -18.97
Percentage change -29.54	%

Peers: ELF LFMD PRGO TDOC GDRX AMWL DOCS CLOV RXRX TWST

| Held by: IJH VTI IWM VB VXF VBK IWO XMHQ MDY IJK

Scroll to Statements

Index	RUT	P/E	65.87	EPS (ttm)	0.69	Insider Own	10.43%	Shs Outstand	215.21M	Perf Week	-18.44%
Market Cap	10.13B	Forward P/E	46.69	EPS next Y	0.97	Insider Trans	-8.69%	Shs Float	190.51M	Perf Month	-21.98%
Enterprise Value	9.87B	PEG	1.90	EPS next Q	0.15	Inst Own	70.32%	Short Float	31.96%	Perf Quarter	30.21%
Income	164.40M	P/S	5.68	EPS this Y	27.49%	Inst Trans	-4.34%	Short Ratio	1.52	Perf Half Y	45.40%
Sales	1.78B	P/B	18.42	EPS next Y	43.43%	ROA	24.54%	Short Interest	60.88M	Perf YTD	87.14%
Book/sh	2.46	P/C	31.39	EPS next 5Y	34.58%	ROE	36.79%	52W High	72.98 -38.00%	Perf Year	82.53%
Cash/sh	1.44	P/FCF	43.05	EPS past 3/5Y	- 17.22%	ROIC	27.00%	52W Low	13.47 235.93%	Perf 3Y	1011.79%
Dividend Est.	-	EV/EBITDA	71.55	Sales past 3/5Y	75.77% -	Gross Margin	68.19%	Volatility	3.54% 4.13%	Perf 5Y	351.59%
Dividend TTM	-	EV/Sales	5.53	EPS Y/Y TTM	6218.70%	Oper. Margin	6.48%	ATR (14)	5.70	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.32	Sales Y/Y TTM	85.99%	Profit Margin	9.21%	RSI (14)	39.35	Recom	2.50
Dividend Gr. 3/5Y	- -	Current Ratio	1.59	EPS Q/Q	313.81%	SMA20	-18.95%	Beta	2.10	Target Price	47.83
Payout	0.00%	Debt/Eq	0.12	Sales Q/Q	110.67%	SMA50	-4.78%	Rel Volume	8.72	Prev Close	64.22
Employees	1637	LT Debt/Eq	0.11	Earnings	May 05 AMC	SMA200	35.16%	Avg Volume	40.04M	Price	45.25
IPO	Sep 13, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	65.43% 8.80%	Trades		Volume	59,122,555	Change	-29.54%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-04-25	Reiterated	Needham	Buy	$61 → $65
Apr-29-25	Downgrade	TD Cowen	Buy → Hold	$30
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$42 → $60
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral	$16 → $20
Apr-16-24	Downgrade	Jefferies	Buy → Hold	$17 → $15
Apr-10-24	Initiated	Canaccord Genuity	Buy	$20
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform	$16
Feb-26-24	Initiated	Leerink Partners	Market Perform	$10
Dec-07-23	Initiated	Imperial Capital	In-line	$9
Jul-28-23	Initiated	TD Cowen	Outperform	$11
Apr-11-23	Initiated	Robert W. Baird	Neutral	$10
Feb-09-23	Upgrade	Jefferies	Hold → Buy	$7 → $11
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$5
Nov-08-22	Upgrade	BofA Securities	Neutral → Buy	$7.50 → $8.50

Show Previous Ratings

Today 09:02AM	IBD 50's Hims Plummets After Novo Yanks Deal Over 'Deceptive' And 'Illegitimate' Wegovy Knockoffs (Investor's Business Daily) -29.54%
10:05AM	Hims & Hers' stock plunges. Here's why Wegovy parent ended its partnership with the company. (MarketWatch)
08:49AM	These Stocks Are Moving the Most Today: Northrop Grumman, Exxon, Tesla, Northern Trust, Fiserv, Hims & Hers, and More (Barrons.com)
08:36AM	Hims & Hers Stock Plunges as Novo Nordisk Abruptly Ends Partnership (Barrons.com)
08:24AM	Hims & Hers stock falls after Novo Nordisk ends weight loss drug pact (Investing.com)
12:49PM	Loading…
Jun-20-25 12:49PM	How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl (Investor's Business Daily) +5.16%
Jun-19-25 12:09PM	Hims & Hers Stock Jumps 85.1% in 3 Months: Is It a Buy Now? (Zacks)
08:35AM	QIAGEN's New QIAcuity dPCR IVD Pact With GENCURIX May Boost Its Stock (Zacks)
08:18AM	ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise? (Zacks)
08:17AM	Should You Add NVST Stock to Your Portfolio Right Now? (Zacks)
08:09AM	How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl (Investor's Business Daily)
Jun-18-25 10:30AM	Where Will Hims & Hers Stock Be in 10 Years? (Motley Fool)
09:22AM	Reasons to Add PAHC Stock to Your Portfolio Right Now (Zacks)
08:30AM	Bet on Winning DuPont Analysis & Pick 3 Top Stocks (Zacks)
08:28AM	Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge? (Zacks)
04:20AM	Loading…
04:20AM	Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth) (Motley Fool)
Jun-17-25 08:39AM	DGX Stock Up on New Blood Test Development Deal With MD Anderson (Zacks)
Jun-16-25 04:00PM	These 2 Growth Stocks Are No-Brainer Buys Right Now (Motley Fool) +7.75%
11:19AM	GEHC Stock Declines Despite Expansion in Precision Care Capabilities (Zacks)
08:27AM	QGEN Stock Rises in After Market Following Partnership With Incyte (Zacks)
08:25AM	Should You Hold Myriad Genetics Stock in Your Portfolio Right Now? (Zacks)
06:20AM	Should First Trust Mid Cap Core AlphaDEX ETF (FNX) Be on Your Investing Radar? (Zacks)
Jun-13-25 12:13PM	Should You Add QIAGEN Stock to Your Portfolio for Now? (Zacks)
09:00AM	Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jun-12-25 10:36AM	HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth (Zacks)
12:01AM	3 Reasons We Love Hims & Hers Health (HIMS) (StockStory)
Jun-11-25 09:32AM	Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to (Yahoo Finance)
08:35AM	Should You Continue to Hold Prestige Consumer Stock in Your Portfolio? (Zacks)
Jun-10-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
04:27PM	Eli Lilly telehealth deals to prevent sale of compounded GLP-1s (Yahoo Finance Video)
08:06AM	Loading…
08:06AM	Bruker Stock Set to Gain From Acquisition of Austria's biocrates (Zacks)
Jun-09-25 05:52PM	Markets Flat on No Economic or Trade News; Apple Flops at WWDC (Zacks)
12:20PM	Why Hims & Hers Health (HIMS) Might be Well Poised for a Surge (Zacks)
12:03PM	Hims & Hers Health, Inc. (HIMS): A Bull Case Theory (Insider Monkey)
08:37AM	PEN Stock Rises Following the Launch of Ruby XL System (Zacks)
Jun-08-25 06:50PM	Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock? (Motley Fool)
Jun-07-25 06:52PM	Is Hims & Hers Health a Smart Buy Right Now? (Motley Fool)
04:15AM	This Monster Growth Stock Is Up 167% in the Past Year and Disrupting the Healthcare Space (Motley Fool)
Jun-05-25 12:20PM	HIMS' Buyouts Fuel International Expansion & Digital Health Innovation (Zacks)
11:31AM	Omnicell (OMCL) Up 27% Since Last Earnings Report: Can It Continue? (Zacks)
08:52AM	Should You Continue to Hold EXAS Sciences Stock in Your Portfolio? (Zacks)
08:29AM	Hims & Hers Stock: Buy the Dip or Wait It Out? (MarketBeat)
06:16AM	Hims & Hers Goes on a Buying Spree (Motley Fool)
Jun-04-25 12:33PM	HIMS Stock Falls Despite Latest Deal to Expand International Footprint (Zacks)
11:30AM	Why Is Hims & Hers Health (HIMS) Up 10.6% Since Last Earnings Report? (Zacks)
08:34AM	Should You Continue to Hold Labcorp Stock in Your Portfolio? (Zacks)
07:15AM	2 Incredible Growth Stocks to Buy Hand Over Fist (Motley Fool)
05:19AM	Zacks.com featured highlights EverQuote, Hims & Hers Health and Sprouts Farmers Market (Zacks)
Jun-03-25 04:11PM	Hims & Hers and Zava, Credo earnings, Kenvue: Trending Tickers (Yahoo Finance Video)
11:50AM	Top Stock Movers Now: Dollar General, Hims & Hers, Bumble, and More (Investopedia)
11:03AM	Hims & Hers Seeks Growth in Europe as Weight-Loss Business Shifts (Barrons.com)
11:03AM	Hims & Hers Expands in Europe With Acquisition of ZAVA (Investopedia)
10:31AM	Hims & Hers, Joby Aviation, Pinterest: Trending Tickers (Yahoo Finance Video)
10:09AM	TMO Launches Next-Generation Mass Spectrometers: Stock to Gain? (Zacks)
10:05AM	The Bull Market is Back: 3 Stocks to Buy Now (HIMS, APP, META) (Zacks)
09:50AM	Why Hims & Hers Health, Inc. (HIMS) is a Top Momentum Stock for the Long-Term (Zacks)
08:53AM	IBD 50's Hims & Hers Erases Its 19% Acquisition-Tied Sprint (Investor's Business Daily)
08:53AM	IBD 50's Hims & Hers Health Shoots Higher On A Key Takeover In Europe (Investor's Business Daily)
08:08AM	QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances (Zacks)
07:41AM	Bet on Winning DuPont Analysis & Pick 3 Top Stocks (Zacks)
07:15AM	Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland (Business Wire)
Jun-02-25 10:18AM	LH Stock Rises Following the Expansion of Precision Oncology Portfolio (Zacks)
09:00AM	Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know (Zacks)
08:12AM	Charles River Stock May Gain From Extended CHDI Research Deal on HD (Zacks)
06:20AM	Should JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) Be on Your Investing Radar? (Zacks)
06:20AM	Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar? (Zacks)
May-30-25 12:21PM	Hims & Hers vs. Amwell: Which Telehealth Stock Is the Better Buy? (Zacks) +7.94%
10:09AM	Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds (Zacks)
09:27AM	Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? (Zacks)
08:16AM	Thermo Fisher Launches New Spectral Flow Cytometer: Stock to Gain? (Zacks)
May-29-25 10:30AM	Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly (Investor's Business Daily)
08:54AM	Bruker Stock to Gain From the Launch of MOVE-T Liquid Dairy Analyzer (Zacks)
May-28-25 12:18PM	Hims & Hers Stock Falls Despite the Latest Wegovy Availability Offer (Zacks)
08:12AM	Illumina's TSO Comprehensive Earns Japan's Approval: Stock to Gain? (Zacks)
04:27AM	Why Hims & Hers Health Inc. (HIMS) Went Down On Tuesday (Insider Monkey)
May-27-25 11:37AM	3 Surprising Stocks That Have More Than Doubled in 2025 (Motley Fool)
May-26-25 08:38AM	TMO Stock Set to Gain From the Launch of New Narcotic Analyzers (Zacks)
06:20AM	Is Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) a Strong ETF Right Now? (Zacks)
May-24-25 02:05PM	Why Hims & Hers Health Stock (HIMS) Is Too Hot to Handle (TipRanks)
07:00AM	MarketBeat Week in Review - 05/19 - 05/23 (MarketBeat)
May-23-25 10:47AM	RVTY Stock Falls Despite the Latest Launch of Automated Instrument (Zacks)
08:53AM	Edwards' New Late-Breaking Data on Severe AS Expected to Boost Stock (Zacks)
May-22-25 04:53PM	Why Hims & Hers Health (HIMS) Stock Is Falling Today (StockStory) -7.72%
03:39PM	Hims & Hers Introduces 6-Month Wegovy New Customer Offer (Business Wire)
01:57PM	Will Hims & Hers Stock Be Okay After UnitedHealth's Sell-Off? (MarketBeat)
11:11AM	Snowflake stock gains, Nvidia & Navitas, Hims & Hers slips (Yahoo Finance Video)
09:33AM	Nvidia, Tesla lead over $250 billion in short-seller losses during massive market rally (Yahoo Finance)
May-21-25 01:08PM	MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio (Zacks) -5.24%
11:36AM	AST Business Growth & Strategic Acquisitions Support STERIS Stock (Zacks)
10:00AM	5 Single-Stock ETFs That Doubled in a Month (Zacks)
09:40AM	Are Medical Stocks Lagging DBV Technologies (DBVT) This Year? (Zacks)
May-20-25 11:31PM	Unpacking Q1 Earnings: Hims & Hers Health (NYSE:HIMS) In The Context Of Other Healthcare Technology Stocks (StockStory)
12:53PM	Why Hims & Hers Health, Inc. (HIMS) Skyrocketed on Friday (Insider Monkey)
10:16AM	Hims & Hers Stock Chart Points to Strong Bullish Continuation (MarketBeat)
08:49AM	Illumina Stock to Gain From the Launch of New DRAGEN v4.4 Software (Zacks)
May-19-25 09:13AM	ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues (Zacks)
07:47AM	Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs (Zacks)
07:02AM	Here's Why You Should Add Hims & Hers Stock to Your Portfolio Now (Zacks)
May-16-25 01:26PM	Hims Stock Rockets On Novo Nordisk Partnership After FDA Weight-Loss Drug Ruling Crashes Shares (Investor's Business Daily) +10.36%
10:25AM	Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now? (Zacks)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chi Michael	Chief Commercial Officer	Jun 17 '25	Sale	59.75	17,102	1,021,844	278,654	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Option Exercise	2.43	125,335	304,564	285,550	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Sale	56.76	128,127	7,271,950	160,215	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 17 '25	Sale	59.22	65,110	3,855,542	95,105	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Sale	56.51	47,534	2,686,300	237,660	Jun 17 08:07 PM
Boughton Soleil	Chief Legal Officer	Jun 16 '25	Sale	56.80	5,451	309,617	165,881	Jun 17 08:06 PM
Boughton Soleil	Chief Legal Officer	Jun 17 '25	Sale	59.75	2,572	153,677	163,309	Jun 17 08:06 PM
Becklund Irene	PAO	Jun 17 '25	Sale	59.75	8,485	506,979	712	Jun 17 08:06 PM
Chi Michael	Officer	Jun 17 '25	Proposed Sale	59.75	17,102	1,021,844		Jun 17 12:42 PM
Dudum Andrew	Officer	Jun 17 '25	Proposed Sale	59.22	65,110	3,855,544		Jun 17 12:13 PM
Becklund Irene	Officer	Jun 17 '25	Proposed Sale	59.75	8,485	506,979		Jun 17 11:19 AM
Boughton Soleil	Officer	Jun 17 '25	Proposed Sale	59.75	2,572	153,677		Jun 17 10:20 AM
Melissa Baird	Officer	Jun 16 '25	Proposed Sale	59.78	33,333	1,992,647		Jun 16 05:58 PM
Dudum Andrew	Officer	Jun 16 '25	Proposed Sale	56.49	47,534	2,685,348		Jun 16 02:42 PM
Boughton Soleil	Officer	Jun 16 '25	Proposed Sale	56.80	5,451	309,617		Jun 16 11:53 AM
Dudum Andrew	Officer	Jun 16 '25	Proposed Sale	56.43	128,127	7,230,643		Jun 16 11:24 AM
Chi Michael	Chief Commercial Officer	Jun 10 '25	Option Exercise	6.82	5,400	36,828	261,980	Jun 11 08:09 PM
Chi Michael	Chief Commercial Officer	Jun 10 '25	Sale	57.00	5,600	319,200	256,380	Jun 11 08:09 PM
Chi Michael	Officer	Jun 10 '25	Proposed Sale	57.00	5,400	307,800		Jun 10 12:12 PM
Chi Michael	Chief Commercial Officer	Jun 05 '25	Option Exercise	13.90	28,776	399,986	256,580	Jun 09 04:58 PM
Chi Michael	Chief Commercial Officer	Jun 06 '25	Option Exercise	13.20	5,100	67,335	260,180	Jun 09 04:58 PM
Chi Michael	Chief Commercial Officer	Jun 06 '25	Sale	56.00	5,100	285,600	256,580	Jun 09 04:58 PM
Chi Michael	Officer	Jun 06 '25	Proposed Sale	56.00	5,100	285,600		Jun 06 01:19 PM
Melissa Baird	Officer	Jun 04 '25	Proposed Sale	53.61	33,333	1,786,982		Jun 04 04:46 PM
Okupe Oluyemi	Chief Financial Officer	May 28 '25	Option Exercise	5.01	6,437	32,249	120,253	May 30 04:28 PM
Okupe Oluyemi	Chief Financial Officer	May 28 '25	Sale	52.98	11,581	613,537	39,153	May 30 04:28 PM
Boughton Soleil	Chief Legal Officer	May 27 '25	Sale	55.87	3,233	180,628	153,194	May 29 05:56 PM
Becklund Irene	PAO	May 22 '25	Sale	53.51	5,071	271,349	0	May 27 04:59 PM
Melissa Baird	Officer	May 27 '25	Proposed Sale	53.36	33,333	1,778,649		May 27 04:44 PM
Boughton Soleil	Officer	May 27 '25	Proposed Sale	55.87	3,233	180,628		May 27 11:12 AM
Becklund Irene	Officer	May 22 '25	Proposed Sale	53.51	5,071	271,349		May 22 09:45 AM
Okupe Oluyemi	Chief Financial Officer	May 15 '25	Option Exercise	10.97	6,437	70,646	125,397	May 19 06:35 PM
Okupe Oluyemi	Chief Financial Officer	May 15 '25	Sale	60.22	11,581	697,462	113,816	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Option Exercise	2.43	125,335	304,564	197,645	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Sale	58.40	128,127	7,482,414	89,311	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Sale	58.25	47,534	2,768,974	285,194	May 19 06:35 PM
Dudum Andrew	Officer	May 16 '25	Proposed Sale	58.36	175,661	10,251,390		May 16 11:08 AM
Baird Melissa	Chief Operating Officer	May 12 '25	Option Exercise	2.43	33,333	80,999	838,416	May 13 05:07 PM
Baird Melissa	Chief Operating Officer	May 12 '25	Sale	56.02	33,333	1,867,376	805,083	May 13 05:07 PM
Boughton Soleil	Chief Legal Officer	May 12 '25	Sale	56.00	3,235	181,160	156,427	May 13 05:07 PM
Melissa Baird	Officer	May 12 '25	Proposed Sale	55.21	33,333	1,840,315		May 12 05:10 PM
Boughton Soleil	Officer	May 12 '25	Proposed Sale	56.00	3,235	181,160		May 12 10:25 AM
Boughton Soleil	Chief Legal Officer	Apr 28 '25	Sale	30.19	3,236	97,695	159,662	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 29 '25	Option Exercise	2.43	50,000	121,500	142,103	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 28 '25	Option Exercise	2.43	41,667	101,251	133,770	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 29 '25	Sale	36.39	50,000	1,819,310	92,103	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 28 '25	Sale	30.19	41,667	1,257,760	92,103	Apr 30 06:01 PM
Dudum Andrew	Officer	Apr 29 '25	Proposed Sale	36.39	50,000	1,819,309		Apr 29 10:51 AM
Dudum Andrew	Officer	Apr 28 '25	Proposed Sale	30.19	41,667	1,257,753		Apr 28 12:51 PM
Boughton Soleil	Officer	Apr 28 '25	Proposed Sale	30.19	3,236	97,695		Apr 28 10:07 AM
Baird Melissa	Chief Operating Officer	Apr 21 '25	Option Exercise	1.97	33,333	65,653	838,416	Apr 23 04:21 PM
Baird Melissa	Chief Operating Officer	Apr 21 '25	Sale	25.78	33,333	859,256	805,083	Apr 23 04:21 PM
Becklund Irene	PAO	Apr 22 '25	Sale	26.49	2,936	77,775	5,071	Apr 23 04:21 PM
Becklund Irene	Officer	Apr 22 '25	Proposed Sale	26.49	2,936	77,775		Apr 22 09:46 AM
Melissa Baird	Officer	Apr 21 '25	Proposed Sale	25.84	33,333	861,325		Apr 21 04:37 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Option Exercise	2.43	33,668	81,813	128,563	Apr 18 03:40 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Sale	28.23	47,534	1,342,094	332,728	Apr 18 03:40 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Sale	28.04	36,460	1,022,453	92,103	Apr 18 03:40 PM
Boughton Soleil	Chief Legal Officer	Mar 03 '25	Sale	45.14	4,151	187,376	166,134	Apr 16 04:30 PM
Boughton Soleil	Chief Legal Officer	Apr 14 '25	Sale	28.72	3,236	92,938	162,898	Apr 16 04:30 PM
Okupe Oluyemi	Chief Financial Officer	Apr 15 '25	Option Exercise	6.43	6,437	41,377	130,541	Apr 16 04:30 PM
Okupe Oluyemi	Chief Financial Officer	Apr 15 '25	Sale	28.50	11,581	330,082	118,960	Apr 16 04:30 PM
Dudum Andrew	Officer	Apr 16 '25	Proposed Sale	28.15	83,994	2,364,547		Apr 16 10:44 AM
Boughton Soleil	Officer	Apr 14 '25	Proposed Sale	28.72	3,236	92,938		Apr 14 09:52 AM
Baird Melissa	Chief Operating Officer	Apr 09 '25	Option Exercise	1.75	33,337	58,340	838,420	Apr 10 04:30 PM
Baird Melissa	Chief Operating Officer	Apr 09 '25	Sale	27.32	33,337	910,687	805,083	Apr 10 04:30 PM
Melissa Baird	Officer	Apr 09 '25	Proposed Sale	29.49	33,337	983,108		Apr 09 04:42 PM
Baird Melissa	Chief Operating Officer	Apr 04 '25	Option Exercise	5.01	40,380	202,304	805,083	Apr 07 04:15 PM
Becklund Irene	PAO	Apr 03 '25	Sale	28.78	2,203	63,402	8,007	Apr 04 04:52 PM
Okupe Oluyemi	Chief Financial Officer	Apr 02 '25	Option Exercise	5.01	6,437	32,249	135,685	Apr 04 04:52 PM
Okupe Oluyemi	Chief Financial Officer	Apr 02 '25	Sale	29.26	11,581	338,833	124,104	Apr 04 04:52 PM
Becklund Irene	Officer	Apr 03 '25	Proposed Sale	28.78	2,203	63,402		Apr 03 10:29 AM
Baird Melissa	Chief Operating Officer	Mar 31 '25	Option Exercise	5.01	13,460	67,435	764,703	Apr 01 04:57 PM
Boughton Soleil	Chief Legal Officer	Mar 31 '25	Sale	27.77	3,236	89,864	170,285	Apr 01 04:57 PM
Boughton Soleil	Officer	Mar 31 '25	Proposed Sale	27.77	3,236	89,864		Mar 31 09:54 AM
Baird Melissa	Chief Operating Officer	Mar 26 '25	Option Exercise	0.40	67,687	27,075	818,930	Mar 27 05:04 PM
Baird Melissa	Chief Operating Officer	Mar 26 '25	Sale	34.84	67,687	2,358,145	751,243	Mar 27 05:04 PM
Melissa Baird	Officer	Mar 26 '25	Proposed Sale	33.36	67,687	2,258,038		Mar 26 04:09 PM
Okupe Oluyemi	Chief Financial Officer	Mar 21 '25	Sale	32.41	23,118	749,176	129,248	Mar 24 04:35 PM
Oluyemi Okupe	Officer	Mar 21 '25	Proposed Sale	34.75	69,442	2,413,110		Mar 21 05:00 PM
Carroll Patrick Harrison	Chief Medical Officer	Mar 18 '25	Sale	34.31	23,287	798,977	209,661	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Option Exercise	2.43	125,335	304,564	226,447	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Sale	33.98	128,127	4,353,124	173,655	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 18 '25	Sale	33.85	78,760	2,666,199	94,895	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Sale	33.64	47,534	1,599,170	380,262	Mar 18 06:35 PM
Boughton Soleil	Chief Legal Officer	Mar 18 '25	Sale	34.31	3,236	111,027	173,521	Mar 18 06:35 PM
Becklund Irene	PAO	Mar 18 '25	Sale	34.31	8,277	283,984	10,210	Mar 18 06:34 PM
Dudum Andrew	Officer	Mar 18 '25	Proposed Sale	33.85	78,760	2,666,200		Mar 18 12:24 PM
Boughton Soleil	Officer	Mar 18 '25	Proposed Sale	34.31	3,236	111,027		Mar 18 10:56 AM
Carroll Patrick Harrison	Officer	Mar 18 '25	Proposed Sale	34.31	23,287	798,977		Mar 18 10:52 AM
Becklund Irene	Officer	Mar 18 '25	Proposed Sale	34.31	8,277	283,984		Mar 18 10:24 AM
Dudum Andrew	Officer	Mar 17 '25	Proposed Sale	33.89	175,661	5,952,296		Mar 17 03:26 PM
Becklund Irene	PAO	Mar 11 '25	Sale	34.77	2,203	76,598	2,203	Mar 13 04:31 PM
Becklund Irene	Officer	Mar 11 '25	Proposed Sale	34.77	2,203	76,598		Mar 11 10:03 AM
Becklund Irene	PAO	Mar 03 '25	Sale	45.14	2,913	131,493	4,406	Mar 05 04:42 PM
Pendarvis Christiane	Director	Mar 05 '25	Proposed Sale	40.00	12,500	500,000		Mar 05 11:40 AM
Becklund Irene	Officer	Mar 03 '25	Proposed Sale	45.14	2,913	131,493		Mar 03 11:59 AM
Boughton Soleil	Officer	Mar 03 '25	Proposed Sale	45.14	4,151	187,376		Mar 03 11:45 AM
Chi Michael	Chief Commercial Officer	Feb 24 '25	Option Exercise	5.01	17,303	86,688	210,904	Feb 25 04:38 PM
Chi Michael	Chief Commercial Officer	Feb 24 '25	Sale	48.14	17,303	832,966	193,601	Feb 25 04:38 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Hims & Hers Health Inc

Upgrade your FINVIZ experience